Biological and clinical results of a neuroimmunotherapy with interleukin-2 and the pineal hormone melatonin as a first line treatment in advanced non-small cell lung cancer.

Схожие документы

• A randomised study with subcutaneous low-dose interleukin 2 alone vs interleukin 2 plus the pineal neurohormone melatonin in advanced solid neoplasms other than renal cancer and melanoma.
  по: Lissoni, P., et al.
  Опубликовано: (1994)
• Immunotherapy with subcutaneous low-dose interleukin-2 and the pineal indole melatonin as a new effective therapy in advanced cancers of the digestive tract.
  по: Lissoni, P., et al.
  Опубликовано: (1993)
• Serum levels of soluble interleukin-2 receptors and their relation to lymphocyte subpopulations in patients with metastatic solid tumours.
  по: Lissoni, P., et al.
  Опубликовано: (1989)
• Serum interleukin-2 levels in relation to the neuroendocrine status in cancer patients.
  по: Lissoni, P., et al.
  Опубликовано: (1990)
• A phase II study of tamoxifen plus melatonin in metastatic solid tumour patients.
  по: Lissoni, P., et al.
  Опубликовано: (1996)